×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| UNICHEM LABORATORIES LTD. | 3885.0 | -18.5 | 3842.5 | -0.26 | 3,523 | 28.2 |
| IOL CHEMICALS & PHARMACEUTICAL | 5590.6 | 339.6 | 5516.9 | 1.16 | 3417 | 32.6 |
| Artemis Medicare Services Limi | 2567.56 | 214.17 | 2497.99 | 1.35 | 3265 | 37.4 |
Unichem Laboratories Ltd.,, with Security Code 506690, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 310.1 | 346.7 | 333.8 | 362.4 | 399.2 | 389.7 | 436.9 | 447.8 | 461.2 | 384.3 |
| Expenses | 318.8 | 338.4 | 341.1 | 343.1 | 368.6 | 349.5 | 372.4 | 373.6 | 386.2 | 358.5 |
| Operating Profit | -8.7 | 8.3 | -7.3 | 19.3 | 30.6 | 40.2 | 64.5 | 74.2 | 75.0 | 25.7 |
| OPM % | -2.82% | 2.4% | -2.19% | 5.33% | 7.66% | 10.31% | 14.76% | 16.57% | 16.27% | 6.7% |
| Other Income | -103.9 | 5.8 | 7.6 | 78.0 | -118.6 | 8.8 | 7.1 | 18.9 | 10.1 | 4.3 |
| Interest | 2.9 | 2.5 | 3.8 | 2.4 | 1.8 | 1.4 | 1.8 | 2.9 | 1.5 | 1.9 |
| Depreciation | 28.3 | 27.4 | 27.3 | 25.6 | 25.2 | 26.1 | 26.4 | 28.5 | 27.5 | 29.9 |
| Profit before tax | -36.2 | -15.7 | -30.8 | 1.3 | 10.7 | 21.5 | 43.4 | 61.8 | 52.1 | -1.9 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -24.1% | -8.6% | 1.1% |
| Net Profit | -143.8 | -15.7 | -30.8 | 69.3 | -115.0 | 21.5 | 43.4 | 46.9 | 51.2 | -1.9 |
| EPS in Rs | -20.43 | -2.23 | -4.38 | 9.85 | -16.33 | 3.04 | 6.15 | 6.63 | 0 | -0.26 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 302.5 | 402.1 | 423.2 | 415.6 | 434.4 | 431.7 | 446.4 | 462.2 | 533.1 | 587.2 |
| Expenses | 345.3 | 385.6 | 395.2 | 406.9 | 396.3 | 406.3 | 402.9 | 404.6 | 447.6 | 503.5 |
| Operating Profit | -42.8 | 16.5 | 28.0 | 8.8 | 38.1 | 25.4 | 43.5 | 57.5 | 85.5 | 83.7 |
| OPM % | -14.14% | 4.1% | 6.62% | 2.11% | 8.77% | 5.87% | 9.74% | 12.45% | 16.04% | 14.26% |
| Other Income | 16.4 | -28.4 | 8.6 | 5.5 | 79.3 | -119.5 | 3.9 | 8.8 | 13.6 | 9.3 |
| Interest | 4.1 | 5.5 | 5.8 | 6.7 | 5.6 | 4.6 | 4.0 | 4.8 | 6.8 | 5.5 |
| Depreciation | 30.8 | 29.7 | 28.8 | 29.5 | 27.9 | 27.2 | 28.3 | 28.5 | 30.5 | 29.7 |
| Profit before tax | -61.3 | -13.6 | 2.1 | -21.9 | 16.0 | -0.2 | 15.0 | 33.0 | 61.9 | 57.8 |
| Tax % | 4.3% | -6.1% | -131.6% | 11.9% | 0% | 2.7% | -38.3% | -7.6% | -6.5% | -8.3% |
| Net Profit | -63.9 | -44.3 | -0.7 | -24.5 | 84.0 | -129.3 | 9.3 | 30.5 | 57.9 | 53.0 |
| EPS in Rs | -9.08 | -6.28 | -0.09 | -3.48 | 11.92 | -18.36 | 1.31 | 4.32 | 8.19 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 14% |
| 3 Years: | 23% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 37% |
| 3 Years: | 70% |
| TTM: | 540% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 38% |
| 3 Years: | 39% |
| 1 Year: | 14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 14% |
| 3 Years: | 18% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 29% |
| 3 Years: | 63% |
| TTM: | 591% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 38% |
| 3 Years: | 39% |
| 1 Year: | 14% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|